- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02177214
Magnetic Resonance Imaging of Mesh Position After Ventral Hernia Repair
Prospective Study to Visualize Dynamesh ® IPOM Visible Mesh With MRI After Laparoscopic Intraperitoneal Ventral Hernia Repair.
Study Overview
Detailed Description
INTRODUCTION:
The repair of ventral hernias always goes along with a discussion about placing the optimal mesh, the optimum mesh position and the optimal fixation method of the mesh against the abdominal wall. There are a lot of meshes available of different materials, in different sizes and with different properties.
Penetrating fixation methods of the mesh have a strong positioning as result, but often at the cost of increased acute postoperative pain. Less or non-permanent (absorbable) fixation may decrease pain but should not risk a less stable mesh fixation ongoing with recurrence due to mesh shifting of mesh shrinkage.
It is indeed known that the majority of implanted meshes do shrink to an extent, which may be of disadvantage for the patient. This has already been demonstrated in several animal studies, but clinical information on the mesh shrinkage is rare and mostly a result from revised surgery.
All ordinary meshes for repair of abdominal hernia defects, based on polymeric textile, are invisible to conventional imaging techniques, inclusive "magnetic resonance imaging" (MRI). The IPOM mesh visible (Dynamesh®), developed by a unique method, contains an amount of iron particles, woven in the ordinary structure of the mesh, which allows an imaging in the MRI.
This study aims to visualize the implanted mesh in vivo by MRI. Furthermore, in cooperation with Dynamesh, we want to investigate the optimal concentration of iron particle resulting in optimal MRI.
PURPOSE Purpose of the study is the visualization of the mesh and the determination of the mesh surface observed by MRI at 3 weeks and 13 months after ventral hernia repair with mesh visible IPOM (Dynamesh®). We want to prove that with this type of mesh it is possible to visualize the mesh position in vivo in a safe manner. This provides long-term benefit to early recognize possible recurrence caused by shifting or shrinking of the mesh and to provide early treatment.
HERNIA REPAIR
- Introduction of the visible mesh IPOM (Dynamesh®) via laparoscopy and positioning against the abdominal wall with a minimum overlap with the hernia defect of at least 5 cm in all directions.
- The mesh will be fixed with absorbable staples, Secure Traps (Ethicon, Johnson & Johnson), in a double crown configuration. The staples are approximately 1.5 to 2 cm at distant from each other.
- All patients receive a standardized pain treatment protocol. Analgesics used will be checked. Visual analog scale (VAS) for pain will be measured at 4 hours, 8 hours, 12 hours, 16 hours, 20 hours and 24 hours post-operatively and every 12 hours thereafter until discharge of the patient.
- Pain medication after discharge will be monitored and checked with the patient at each consultation.
Clinical follow-up: clinical follow-up evaluations of patients at 1 and 13 months.
MRI measurement: post-operative scans and MRI analysis at 1 and 13 months.
DATA PROTECTION AND PRIVACY OF THE PATIENT All information about this study will be collected in EuraHS registry. The data will be entered into the EuraHS platform with a coded number, IMAP001, IMAP002, ...
LONG-TERM OUTCOME The ability to visualize the position of the intra-abdominal surgery mesh on the abdominal wall in a secure manner would be a huge step in abdominal wall surgery. It would give the surgeon the opportunity to quickly identify a possible loosening or moving or shrinking of the prosthesis and thus to prevent recurrence and other long-term complications.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium, 9000
- AZ Maria Middelares
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients scheduled for elective laparoscopic repair of ventral hernia
Exclusion Criteria:
- - <18 years
- Lateral hernias (L1-L4), subxyphoidale hernias (M1) or suprapubicale hernias (M5).
- Emergency surgery (incarcerated hernia)
- Clean-contaminated or contaminated procedures
- ASA score> 4
- Pregnancy
- No patient Informed Consent
- Life expectancy of less than 2years
- Contra-indications for MRI examination, as of:
- Implanted electronic devices such as a pacemaker, neuro-stimulator, cochlear implant.
- Not MRI-compatible valves.
- Metal foreign bodies (depending on the location relative to the region to investigate).
- Large tattoos. Note: By default, the patient has to complete a questionnaire before the start of the study. This will be followed with the radiology nurse post-MRI.
- Claustrophobia, shortness of breath, tremor.
- In doubt, an internationally accepted list of items will be checked on the website www.mrisafety.com.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
ventral hernia
Adult patients scheduled for elective laparoscopic repair of ventral hernia, with inclusion of primary and incisional hernias.
Visualization of the mesh surface observed with MRI scan at 3 weeks and 13 months after ventral hernia repair with a visible IPOM prosthesis (Dynamesh®)
|
Visualization of the mesh surface observed with MRI scan at 3 weeks and 13 months after ventral hernia repair with a visible IPOM prosthesis (Dynamesh®)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visualization
Time Frame: 3 weeks
|
Clear visualization of the MRI IPOM prosthesis 3 weeks postoperatively
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mesh surface
Time Frame: 13 month
|
Calculation of mesh surface in comparison and% difference; visualization of IPOM prosthesis at 13 months postoperatively with MRI.
|
13 month
|
Collaborators and Investigators
Investigators
- Principal Investigator: Filip Muysoms, MD, Algemeen ziekenhuis Maria Middelares
Publications and helpful links
General Publications
- Muysoms FE, Novik B, Kyle-Leinhase I, Berrevoet F. Mesh fixation alternatives in laparoscopic ventral hernia repair. Surg Technol Int. 2012 Dec;22:125-32.
- Muysoms F, Beckers R, Kyle-Leinhase I. Prospective cohort study on mesh shrinkage measured with MRI after laparoscopic ventral hernia repair with an intraperitoneal iron oxide-loaded PVDF mesh. Surg Endosc. 2018 Jun;32(6):2822-2830. doi: 10.1007/s00464-017-5987-x. Epub 2017 Dec 21.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IMAP STUDY
- EuraHS (Registry Identifier: EuraHS)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recurrence
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Chinese PLA General HospitalRecruitingHCC | Recurrence TumorChina
-
Paracelsus Medical UniversityHeinrich-Heine University, Duesseldorf; Poznan University of Medical Sciences; University Hospital of Ferrara and other collaboratorsCompletedToxicity | Local Neoplasm RecurrenceAustria
-
General Hospital GroeningeUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; University Hospital, Ghent and other collaboratorsNot yet recruiting
-
Dallas VA Medical CenterTerminatedSolid Tumors | Cancer RecurrenceUnited States
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence
-
German Centre for Assessment and Evaluation of...Not yet recruitingComplication | Continence | Potency | Biochemical RecurrenceGermany
-
The University of Hong KongNot yet recruitingCancer | Fear of Cancer Recurrence
-
RottapharmTerminatedHCV Recurrence After Liver Transplantation
-
The University of Hong KongHealth and Medical Research FundNot yet recruitingCancer | Fear of Cancer Recurrence | Psychooncology
Clinical Trials on MRI scan
-
University of ChicagoRecruitingBreast CancerUnited States
-
Jeffrey A. Lieberman, MDTerminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedSchizophreniaUnited States
-
Radboud University Medical CenterCompletedHead and Neck NeoplasmsNetherlands
-
The Clatterbridge Cancer Centre NHS Foundation...Unknown
-
Amsterdam UMC, location VUmcMRIguidance B.V.CompletedSinusitis | Hearing Loss | Head and Neck Tumor | Cholesteatoma | Imaging of Bony Structures of the Head (Various Conditions)Netherlands
-
West China HospitalRecruiting
-
Imperial College LondonRecruitingDiastolic DysfunctionUnited Kingdom
-
University of LeicesterNational Institute for Health Research, United KingdomCompletedPatients With Heart Failure and Preserved Ejection Fraction - HFpEF | Patients With Heart Failure With Reduced Ejection Fraction - HFrEF | Healthy Controls Group - Age and Sex-matched
-
University Hospitals Bristol and Weston NHS Foundation...Bosum Buddies; Friends of the Bristol Haematology and Oncology CentreTerminated